{"id":"W4391091436","doi":"10.1200/jco.2024.42.3_suppl.747","title":"A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cytokine release syndrome; Chimeric antigen receptor; Internal medicine; Immunotherapy; Refractory (planetary science); T cell; Oncology; Pharmacokinetics; Chemotherapy; Leukapheresis; Gastroenterology; Immunology; Immune system; Cancer; Stem cell; CD34","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001597868,0.001235459,0.001036544,0.000387507,0.0003684324,0.0008396572,0.0008756833,0.001269525,0.005334103],"category_scores_gemma":[0.0007620596,0.0004234593,0.0007515799,0.0003590788,0.0008730973,0.0006910794,0.000309921,0.002573288,0.001453387],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008248181,"about_ca_system_score_gemma":0.001764575,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007107798,"about_ca_topic_score_gemma":0.001205144,"domain_scores_codex":[0.999606,0.0001995774,0.00001711292,0.00005757633,0.00003777727,0.00008192999],"domain_scores_gemma":[0.9993027,0.0001195798,0.0001306314,0.00006990008,0.00003874549,0.0003383477],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7932594,0.07694533,0.005969037,0.0007270194,0.0009259086,0.0005665042,0.0002250851,0.00190216,0.0402423,0.0004465006,0.006954351,0.07183641],"study_design_scores_gemma":[0.6760928,0.3125297,0.004323229,0.0000261776,0.0002312542,0.000341606,0.00003536624,0.0008050532,0.003037703,0.000239604,0.002325557,0.00001200761],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884952,0.001503593,0.000503556,0.0005423416,0.0001386327,0.004147086,0.001737997,0.0001090173,0.002822702],"genre_scores_gemma":[0.9810321,0.00130611,0.001704019,0.001247473,0.0002080262,0.004873962,0.005231312,0.00003705171,0.004359963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005334103,"threshold_uncertainty_score":0.01784438,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1868673389277022,"score_gpt":0.5374342180194681,"score_spread":0.3505668790917659,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}